NEW YORK (GenomeWeb News) – Under a new strategic partnership, TrimGen will develop technology for Spartan Bioscience and Spartan will distribute TrimGen products in Canada, Ottawa-based Spartan said today.
 
TrimGen has agreed to develop real-time PCR reagents and kits for the Spartan DX device. Coupling the Spartan DX with TrimGen’s real-time PCR assays allows Spartan to offer “a complete solution for rapid DNA testing,” Spartan Bioscience CEO Paul Lem said in a statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.